P

Proto Script Pharmaceutical Corp
OTC:PSCR

Watchlist Manager
Proto Script Pharmaceutical Corp
OTC:PSCR
Watchlist
Price: 0.0001 USD -66.67% Market Closed
Market Cap: 4.9k USD

Proto Script Pharmaceutical Corp
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Proto Script Pharmaceutical Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
P
Proto Script Pharmaceutical Corp
OTC:PSCR
Revenue
$605k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Proto Script Pharmaceutical Corp
Glance View

Market Cap
4.9k USD
Industry
N/A

Proto Script Pharmaceutical Corp. engages in the provision of mobility solutions. The company is headquartered in Rancho Cucamonga, California. The company went IPO on 2011-11-25. The firm is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The firm has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The firm's health care insurance contracts allow it the ability to service patients nationally. The firm intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The firm currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.

PSCR Intrinsic Value
Not Available
P

See Also

What is Proto Script Pharmaceutical Corp's Revenue?
Revenue
605k USD

Based on the financial report for Sep 30, 2017, Proto Script Pharmaceutical Corp's Revenue amounts to 605k USD.

What is Proto Script Pharmaceutical Corp's Revenue growth rate?
Revenue CAGR 1Y
76%

Over the last year, the Revenue growth was 76%.

Back to Top